Skip Navigation
United States Flag

An official website of the United States government. Here's how you know >

A New Look for HHS-OIG. Learn More >>

Change Font Size

Audit (A-01-09-00609)

Review of Maine's Compliance With the 'Reimbursement of State Costs for Provision of Part D Drugs' Medicare Demonstration Project Requirements

Executive Summary

The Medicare demonstration project reimbursed States for drug costs and related administrative costs incurred during the transition to Medicare Part D. Dually eligible beneficiaries are eligible for both Medicare and Medicaid.

Maine complied with certain provisions of the Medicare demonstration application when claiming drug costs for full-benefit dually eligible beneficiaries. In addition, the State did not claim drug costs to the Medicaid program and the Medicare demonstration project. Accordingly, this report contains no recommendations.

Complete Report

Download the complete report (PDF)

Adobe® Acrobat® is required to read PDF files.

Copies can also be obtained by contacting the Office of Public Affairs at 202-619-1343.

Office of Inspector General, U.S. Department of Health and Human Services | 330 Independence Avenue, SW, Washington, DC 20201